{"biological_condition":["5-aza-2’-deoxycytidine (decitabine; Sigma, A3656) dissolved in DMSO to 10mM. Drug was administered at 1uM daily for 3 days. Control K562 cells were mock treated with DMSO."],"cell_line":["K562 (myelogenous leukemia)"],"identifier":["EXP032764","GSE50610","GSM1224659","GSM1224660"],"jaspar_id":["MA0139.1"],"prediction_models":["DAMO"],"tf_id":"EXP032764.K562_myelogenous_leukemia.CTCF","tf_name":"CTCF","tfbs":[{"DAMO":[{"adj_centrimo_pvalue":-113.287298799046,"distance_threshold":"69","jaspar_id":"MA0139","jaspar_version":"1","score_threshold":"75.7","total_tfbs":"62574","model_detail":"","bed_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP032764.K562_myelogenous_leukemia.CTCF/EXP032764.K562_myelogenous_leukemia.CTCF.MA0139.1.damo.bed","fasta_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP032764.K562_myelogenous_leukemia.CTCF/EXP032764.K562_myelogenous_leukemia.CTCF.MA0139.1.damo.fa","summary_plot_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP032764.K562_myelogenous_leukemia.CTCF/EXP032764.K562_myelogenous_leukemia.CTCF.MA0139.1.damo.png"}]}],"total_peaks":"67965"}